Table 1 The relationship between miR-130a expression and clinicopathological characteristics of patients with HCC.

From: Dexmedetomidine promotes apoptosis and suppresses proliferation of hepatocellular carcinoma cells via microRNA-130a/EGR1 axis

Variables

Cases (n = 83)

miR-130a expression

P-value

High (n = 42)

Low (n = 41)

Age (years)

   

0.658

 ≤55

35

19

16

 

 >55

48

23

25

 

Gender

   

0.314

 Female

20

8

12

 

 Male

63

34

29

 

HBV infection

   

0.469

 Present

59

28

31

 

 Absent

24

14

10

 

AFP (ng/mL)

   

0.119

 ≤200

34

21

13

 

 >200

49

21

28

 

Tumor size (cm)

   

0.014

 ≤5

50

31

19

 

 >5

33

11

22

 

Cellular differentiation

   

0.024

 I–II

62

36

26

 

 III–IV

21

6

15

 

TNM tumor stage

   

0.019

 I–II

57

34

23

 

 III–IV

26

8

18

 
  1. HBV Hepatitis B Virus, AFP alpha-fetoprotein, TNM Tumor node metastasis.
Back to article page